Clinical Report: Modeling Propofol Dosage Needs for Advanced GI Endoscopy
Overview
This study evaluates the relationship between comorbidity burden, age, and propofol requirements during advanced gastrointestinal endoscopy. A model was developed to predict individualized sedation needs based on the Charlson Comorbidity Index and age-adjusted factors, with a focus on its validation.
Background
The increasing number of elderly patients with multiple comorbidities undergoing advanced gastrointestinal endoscopy necessitates a better understanding of sedation requirements. Propofol is commonly used for deep sedation in these procedures, but its administration can be complicated by patient comorbidities, which may affect sedation depth and safety.
Data Highlights
Variable
Association with Propofol Requirement
Older Age
Lower probability of higher propofol requirement
Male Sex
Lower probability of higher propofol requirement
Longer Procedure Duration
Lower probability of higher propofol requirement
Higher CCI
Lower probability of higher propofol requirement
AUC (Training Cohort)
0.831 (95% CI 0.808–0.853)
AUC (Validation Cohort)
0.841 (95% CI 0.780–0.882)
Key Findings
Older age, male sex, and higher comorbidity burden are associated with lower propofol requirements.
The study included 1,555 adult patients undergoing advanced gastrointestinal endoscopy.
Logistic regression analyses classified patients into higher- and lower-propofol requirement groups.
The model demonstrated good discrimination in both training and validation cohorts.
Further external validation of the model is required.
Clinical Implications
Understanding the factors influencing propofol requirements can aid in tailoring sedation strategies for patients undergoing advanced gastrointestinal endoscopy. This may enhance patient safety and procedural outcomes, particularly in those with significant comorbidities.
Conclusion
The study provides a validated model for predicting propofol dosage needs based on age and comorbidity.
